In biotech? A lot of them. Have you seen the price tags on some of the emerging ASO or cas9 related treatments? Many are six figures yearly, some 7 figures administered on a one time basis, yet you still have companies with less bleeding edge research getting investors and grants. The point here is that these are novel treatments. I fully understand if Stemson was about to launch commercially that people wouldn't want to back similar science at 5x the cost, but neither are close to commercialization and there is no current treatment available.
You're oldy fixated on this one aspect of the treatments. In the end it doesn't matter.
Not really what I meant. Those six figure treatments are superior to the cheaper ones, so that justifies the price. Is Tsuji's HM superior to Stemson's? I don't think so, so how is he going to get customers? Why would anyone pay such a premium for something that isn't better?
We really don't know if they end up being sensitive and how negative that will affect such treatment. Such approach is critical for Androgenetic Alopecia, as Tsuji said.
No of course you take into account the competitive landscape, but that's why I said it's irrelevant because there isn't one. All we have here is two companies with semi completed pre-clinical programs, in an marketplace worth several billion that is almost completely unserved besides hair transplants (and this would basically end the hair transplant industry in it's current form). I can't see why it would ever be a factor.
Yeah, my point is that whether it's sensitive or not is irrelevant. You'd still be the first wave of people to ever regain natural density/perfect hair, even if it starts thinning again after a few years. If the procedure isn't permanent the price will be much more affordable anyways.
Good point.
Who cares how many billions it's worth if you're only getting 10% interest on a bond then all it's worth is 10% interest. Now if you're getting 10% interest in the company that's a different story. Tsuji may be reluctant to give anyone interest in the company. I think from the way you're speaking now you thought I meant 10% of shares earlier. Yeah, that would be worth the risk. A 10% interest-bearing loan would not be worth the risk on something that hasn't had a clinical trial. I don't know what kind of venture capitalist would make that deal, but they won't be making many more deals being that stupid.
You're not reasoning at all, you're just being a doomer, and you think I'm a coper so there's nothing left to discuss.
I thought we were talking about a 10% stake in the company.
That's what I meant. I guess I worded that poorly since everyone misunderstood. If the transplanted hair was androgen-sensitive then he wouldn't be able to do offer free top-ups, so this implies two things: 1. that the transplanted hair will be permanent 2. that if you continue to lose your native hairs they will replace them for free.
It's included in the initial cost
I have. Japanese lie too, they are human. I believe that it is not Tsuji's case in this subject.
You forgot that most people on here will dress up as a girl in the end of the decade, if no cure comes along. Lol!
In general: no, because I think with all advances in science, hair loss will be cured sooner rather than later.
Poor mice, no more jobs for them...
I hate tsuji so much for delaying the haircloning with this funding BS . His holding a cure that can change our life
is about artificial skin. Our brother Takashi Tsuji seems to be making good progress here too. Article is about a week old.
in the end it's kind of about hair too
